Levine SZ - Search Results

1

Delayed- and early-onset hypotheses of antipsychotic drug action in the negative symptoms of schizophrenia.

Levine SZ, Leucht S. Levine SZ, et al. Eur Neuropsychopharmacol. 2012 Nov;22(11):812-7. doi: 10.1016/j.euroneuro.2012.03.001. Epub 2012 Apr 14. Eur Neuropsychopharmacol. 2012. PMID: 22507686

2

Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.

Levine SZ, Rabinowitz J, Engel R, Etschel E, Leucht S. Levine SZ, et al. Schizophr Res. 2008 Jan;98(1-3):318-22. doi: 10.1016/j.schres.2007.09.006. Epub 2007 Oct 18. Schizophr Res. 2008. PMID: 17949948

3

Pathways to functional outcomes in schizophrenia: the role of premorbid functioning, negative symptoms and intelligence.

Brill N, Levine SZ, Reichenberg A, Lubin G, Weiser M, Rabinowitz J. Brill N, et al. Among authors: levine sz. Schizophr Res. 2009 May;110(1-3):40-6. doi: 10.1016/j.schres.2009.02.016. Epub 2009 Mar 17. Schizophr Res. 2009. PMID: 19297133

4

Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories.

Levine SZ, Leucht S. Levine SZ, et al. Biol Psychiatry. 2010 Jul 1;68(1):86-92. doi: 10.1016/j.biopsych.2010.01.012. Epub 2010 Mar 15. Biol Psychiatry. 2010. PMID: 20227681

5

Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study.

Levine SZ, Rabinowitz J, Case M, Ascher-Svanum H. Levine SZ, et al. J Clin Psychopharmacol. 2010 Aug;30(4):446-9. doi: 10.1097/JCP.0b013e3181e68e80. J Clin Psychopharmacol. 2010. PMID: 20631562

6

Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.

Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M. Baloush-Kleinman V, et al. Among authors: levine sz. Schizophr Res. 2011 Aug;130(1-3):176-81. doi: 10.1016/j.schres.2011.04.030. Epub 2011 Jun 1. Schizophr Res. 2011. PMID: 21636254

7

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study.

Levine SZ, Rabinowitz J, Ascher-Svanum H, Faries DE, Lawson AH. Levine SZ, et al. Schizophr Res. 2011 Dec;133(1-3):42-6. doi: 10.1016/j.schres.2011.09.018. Epub 2011 Oct 14. Schizophr Res. 2011. PMID: 22000938 Clinical Trial.

8

Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial.

Levine SZ, Rabinowitz J, Faries D, Lawson AH, Ascher-Svanum H. Levine SZ, et al. Schizophr Res. 2012 May;137(1-3):141-6. doi: 10.1016/j.schres.2012.01.014. Epub 2012 Feb 7. Schizophr Res. 2012. PMID: 22316567

9

Early symptom response to antipsychotic medication as a marker of subsequent symptom change: an eighteen-month follow-up study of recent episode schizophrenia.

Levine SZ, Leucht S. Levine SZ, et al. Schizophr Res. 2012 Nov;141(2-3):168-72. doi: 10.1016/j.schres.2012.08.030. Epub 2012 Sep 18. Schizophr Res. 2012. PMID: 22995933 Clinical Trial.

10

Attaining and sustaining remission of predominant negative symptoms.

Levine SZ, Leucht S. Levine SZ, et al. Schizophr Res. 2013 Jan;143(1):60-4. doi: 10.1016/j.schres.2012.11.010. Epub 2012 Dec 4. Schizophr Res. 2013. PMID: 23218563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters